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Biologics development leading to approval can take decades. Acceleration of this timeline is necessary to bring 
safe and efficacious drugs to patients as early as possible.  One research focus to reduce development time is 
the cell culture process development and optimization. In this study, we will present two computational 
strategies that cover: (1) enhancing cell culture media by amino acid optimization using Orthogonal-Partial Least 
Squares (OPLS) regression, and (2) modulating protein glycosylation by altering small molecule compound 
concentrations based on the Concentration Impact Factor. 
Disproportionate nutrient balance in cell culture medium can have a negative impact on cell culture 
performance. In our study, OPLS regression was used to explain cell growth and monoclonal antibody (mAb) 
production dynamics from Chinese Hamster Ovary (CHO) cells as a function of amino acid (AA) stoichiometric 
balances.  The OPLS model was trained on metabolic data from 24 concurrent 14-day fed-batch cultures. 
Metabolic fluxes and respective stoichiometric balances were then generated by calculating the difference 
between the theoretical biomass demand of each AA and the actual AA usage towards mAb production and 
experimental consumption. As a result, highly weighted stoichiometric balances represented those AA that could 
potentially enhance the previous feed medium and aim to achieve a higher intracellular catabolic activity. 
Accordingly, we used our computational model to generate varied amino acid additions to either a platform feed 
or a low nutrient feed by means of a 16-run mixture design. The experimental results showed that addition of 
model generated key AA resulted in a ~55% increase in peak cell density and ~90% increase in mAb 
production, respectively.  
Appropriately glycosylated therapeutic mAb are critical for the proper molecular folding, stability, and in-vivo 
efficacy of the expressed proteins. Cell culture process conditions and medium compositions have been 
demonstrated to affect the expression of various glycosylation species. In this study, we evaluated a set of 
selected small compound for their potential in modifying glycosylation levels in mAb expressed in three different 
proprietary CHO cell lines. These small molecule compounds were first tested on one cell line to establish a 
baseline.  To quantitate the glycosylation modifications, we have developed a mathematical correlation of a 
dimensionless number, termed Concentration Impact factor (Cf), to describe the degree changes in 
glycosylation species. Using the Cf algorithm established for the 1st cell line, we subsequently tested with other 
two cell lines, and were able to modulate and confirmed the level of glycan expression.  This indicates that Cf 
correlation may serve as a tool to provide early assessment of final glycosylation profiles and levels on 
therapeutic proteins due to small molecule supplementations. 
Overall, the two computational methods presented here are aimed to enhance biologics development speed as 
well as ensure product quality control. 
